# Change the Dose Frequency of Controlled-Release Oxycodone to Refractory Pain

> **NCT03639415** · PHASE4 · WITHDRAWN · sponsor: **Fujian Cancer Hospital**

## Conditions studied

- Cancer Pains

## Interventions

- **DRUG:** Increasing the Controlled-Release Oxycodone dose frequency

## Key facts

- **NCT ID:** NCT03639415
- **Lead sponsor:** Fujian Cancer Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-10-30
- **Primary completion:** 2020-10-30
- **Final completion:** 2021-03-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** There is no fund to support
- **Last updated:** 2021-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03639415

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03639415, "Change the Dose Frequency of Controlled-Release Oxycodone to Refractory Pain". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03639415. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*